Uber Stock Dips Following 116 Billion Bid for Delivery Hero Analysts See Strategic Rationale
GitHubs AI Coding Edge Slips Amid Outages and Rising Competition Testing Microsofts Strategy
Safepoints Potential 116 Billion Valuation Highlights Growing Interest in Florida Insurer IPO
US Consumer Spending Squeeze Looms as TrumpEra Tax Rebates Wane and Fuel Costs Surge
RBI Dividend Payout and Geopolitical Tensions Key Factors Shaping Indian Stock Market This Week
Japan Set to Initiate Mercosur Trade Negotiations Focusing on Oil Imports and Auto Exports
HWCPZ Q1 2026 Earnings EPS Slightly Above Estimates Subordinated Notes Gain 018
MRVL Q1 2026 Earnings Slight EPS Miss Despite Positive Market Response
SUZ Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Favorable Pulp Market
IBCP Q1 2026 Earnings Earnings Beat Expectations Amid Modest Stock Decline
RRR Q1 2026 Earnings Earnings Beat Estimates as Stock Rises 332
Tri Pointe Homes Inc TPH Holds Steady Near 47 as Housing Sector Consolidates
ArriVent BioPharma AVBP Eases 168 Support at 261 in Focus After Sector Headwinds
Hudson Pacific Properties HPP Edges Lower as Office REIT Faces Cautious Investor Sentiment
CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223
Editas Medicine Gains 337 as Gene Editing Biotech Tests Key Resistance at 29
The Rise of the MultiJob Workforce Economic Pressures Reshape Employment
Ball Corporation Q1 2026 Earnings EPS Surprises to the Upside as Cost Initiatives Gain Traction
Sound Point Meridian Capital Preferred Shares SPMA Edge Lower as Trading Remains RangeBound
eXoZymes Inc EXOZ Surges 55 Key Levels to Watch After the Rally
Calamos Strategic Total Return CSQ Consolidates Near Resistance Eyes Potential Upside Breakout
Titan Machinery TITN Consolidates Near Support as Agricultural Sector Uncertainty Persists
Definium Therapeutics DFTX Surges 341 as Volume Picks Up Testing Key Resistance
Manhattan Associates MANH Edges Higher Near Key Resistance as Supply Chain Tech Momentum Holds
Palomar Holdings PLMR Falls 442 as Support and Resistance Levels Take Center Stage
Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback